The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Tobias W. Klausen, Henrik Gregersen, Niels Abildgaard, Niels Frost Andersen, Ulf Christian Frølund, Peter Gimsing, Carsten Helleberg, Annette J. Vangsted*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
TidsskriftLeukemia
Vol/bind33
Udgave nummer2
Sider (fra-til)546–549
ISSN0887-6924
DOI
StatusUdgivet - 1. feb. 2019

Citer dette

Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., ... Vangsted, A. J. (2019). The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials. Leukemia, 33(2), 546–549. https://doi.org/10.1038/s41375-018-0272-0
Klausen, Tobias W. ; Gregersen, Henrik ; Abildgaard, Niels ; Andersen, Niels Frost ; Frølund, Ulf Christian ; Gimsing, Peter ; Helleberg, Carsten ; Vangsted, Annette J. / The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials. I: Leukemia. 2019 ; Bind 33, Nr. 2. s. 546–549.
@article{ac225f139f0042f4a4d054235baa9b31,
title = "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials",
author = "Klausen, {Tobias W.} and Henrik Gregersen and Niels Abildgaard and Andersen, {Niels Frost} and Fr{\o}lund, {Ulf Christian} and Peter Gimsing and Carsten Helleberg and Vangsted, {Annette J.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1038/s41375-018-0272-0",
language = "English",
volume = "33",
pages = "546–549",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "2",

}

Klausen, TW, Gregersen, H, Abildgaard, N, Andersen, NF, Frølund, UC, Gimsing, P, Helleberg, C & Vangsted, AJ 2019, 'The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials', Leukemia, bind 33, nr. 2, s. 546–549. https://doi.org/10.1038/s41375-018-0272-0

The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials. / Klausen, Tobias W.; Gregersen, Henrik; Abildgaard, Niels; Andersen, Niels Frost; Frølund, Ulf Christian; Gimsing, Peter; Helleberg, Carsten; Vangsted, Annette J.

I: Leukemia, Bind 33, Nr. 2, 01.02.2019, s. 546–549.

Publikation: Bidrag til tidsskriftLetterForskningpeer review

TY - JOUR

T1 - The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

AU - Klausen, Tobias W.

AU - Gregersen, Henrik

AU - Abildgaard, Niels

AU - Andersen, Niels Frost

AU - Frølund, Ulf Christian

AU - Gimsing, Peter

AU - Helleberg, Carsten

AU - Vangsted, Annette J.

PY - 2019/2/1

Y1 - 2019/2/1

U2 - 10.1038/s41375-018-0272-0

DO - 10.1038/s41375-018-0272-0

M3 - Letter

VL - 33

SP - 546

EP - 549

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -